Effects of Different Exercise Training Regimens on Visceral Fat Dynamic and Resting Energy Expenditure in Obese Patients

May 27, 2015 updated by: Matthias Bluher, University of Leipzig

Monocentric, Randomized, Controlled Study for Reduction on Visceral Fat Dynamic and Resting Energy Expenditure in Obese Patients Via Strength Versus Endurance Training (STEN Study - STrength Versus ENdurance Training)

In this project, the investigators will test the hypothesis that predominant (two to three times a week 60 min) strength training is more effective in reducing visceral fat mass than endurance training in obese patients.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Strength training (ST) was shown to be more effective than endurance training (ET) in improving glycemic control in the treatment of type 2 diabetes. However, it is unknown, whether different training strategies have different effects on the preferential visceral adipose tissue reduction and changes in resting energy expenditure in a population with abdominal obesity. We will therefore compare ST and ET (two to three times a week, 60 minutes per training session) in addition to a restricted energy intake of 1500kcal per day for women and 1800kcal per day for men in a prospective study of 200 individuals with abdominal obesity defined by a waist circumference > 102 cm for males and > 88 cm for females and a BMI > 35 kg/m² with regard to:

  1. Abdominal visceral adipose tissue area dynamic (MRI studies)
  2. Abdominal subcutaneous adipose tissue area dynamic (MRI studies)
  3. Total body fat mass changes (bioelectrical impedance analysis)
  4. Changes in resting energy expenditure (indirect calorimetry)
  5. Changes in parameters of glucose metabolism, insulin sensitivity and lipid profile
  6. Changes in circulating adipokines and markers of inflammation In addition, we will search for novel serum parameters, which predict the individual training response by a serum metabolomics/ proteomics approach.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI >= 35 kg/m2
  • waist circumference >102cm (men), >88cm (women)
  • age 18 - 60 years
  • written informed consent

Exclusion Criteria:

  • type 1 or type 2 diabetes
  • fasting plasma glucose >= 6.0 mmol/l
  • 2h-OGTT (oral glucose tolerance test) glucose >= 11.1 mmol/l
  • any chronic inflammatory or malignant disease
  • medical treatment which influences glucose metabolism
  • drug or alcohol abuse
  • psychiatric disorders
  • untreated thyroid dysfunction
  • cardiac pacemaker or other contraindication for MRI
  • attendant therapy with oral antidiabetic medication, GLP-1 mimetics or analoga, Insulin, anti-obesity medication (orlistat, sibutramine), Falithrom, antipsychotic drugs, any chemotherapeutics
  • pregnant or nursing women
  • expected low compliance
  • current participation in another investigational trial
  • last exercise training <= 6 months ago

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: endurance training

Endurance training:

Supervised, twice a week, each training session consists of a 20 min warm up and cool down period and a minimum of 40min tread mill, rawing device or bicycle training.

During the study period of 24 months, we will perform an open randomized, prospective training intervention study comparing the effects of three times a week either strength or endurance training on reduction of visceral fat area as determined by MRI scans at the level of L4-L5.

comparison of strength versus endurance training (two or three times a week, 60 minutes per training session) over 24 months
Active Comparator: strength training

Strength training:

Supervised, twice a week, each training session consists of a 20 min warm up and cool down period and a minimum of 40min circle training

During the study period of 24 months, we will perform an open randomized, prospective training intervention study comparing the effects of two to three times a week either strength or endurance training on reduction of visceral fat area as determined by MRI scans at the level of L4-L5.

comparison of strength versus endurance training (two or three times a week, 60 minutes per training session) over 24 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRI
Time Frame: Baseline and after 12 months after randomisation
Change from Baseline in abdominal visceral fat area as determined by MRI scans at the level of L4-L5 after 12 months of training intervention
Baseline and after 12 months after randomisation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRI
Time Frame: Baseline, 12 and 24 months after randomisation
Changes from Baseline in abdominal visceral and subcutaneous fat area
Baseline, 12 and 24 months after randomisation
BIA
Time Frame: Baseline, 6, 12, 18 and 24 months after randomisation
Changes from Baseline in total body fat mass
Baseline, 6, 12, 18 and 24 months after randomisation
compliance to the intervention
Time Frame: over 24 months of intervention
compliance to the intervention of training (strength or endurance) as measured by the number of realized training units. Non-compliance = cumulative time bigger than six weeks per year
over 24 months of intervention
well being as measured by SF-36
Time Frame: Baseline and every 6 months during intervention
Changes from Baseline in individual well being as measured by SF-36
Baseline and every 6 months during intervention
indirect calorimetry
Time Frame: Baseline, 6, 12, 18 and 24 months after randomisation
Changes from Baseline in resting energy expenditure
Baseline, 6, 12, 18 and 24 months after randomisation
fasting plasma glucose
Time Frame: Baseline and every 12 months
Changes from Baseline in fasting plasma glucose, insulin sensitivity and insulin secretion determined in oral glucose tolerance tests
Baseline and every 12 months
inflammatory parameters
Time Frame: Baseline and every 3 months during intervention
Changes from Baseline in inflammatory parameters
Baseline and every 3 months during intervention
adipokine serum concentrations
Time Frame: Baseline and every 3 months during intervention
Changes from Baseline in adipokine serum concentrations
Baseline and every 3 months during intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthias Blüher, prof., MD, University of Leipzig

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Anticipated)

January 1, 2016

Study Completion (Anticipated)

April 1, 2016

Study Registration Dates

First Submitted

May 11, 2011

First Submitted That Met QC Criteria

September 14, 2011

First Posted (Estimate)

September 15, 2011

Study Record Updates

Last Update Posted (Estimate)

May 28, 2015

Last Update Submitted That Met QC Criteria

May 27, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • STEN

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Obesity

Clinical Trials on exercise training

3
Subscribe